Actively Recruiting

Age: 18Years +
All Genders
NCT06499701

Volume Kinetics of Fluid Resuscitation in Early Sepsis

Led by Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu · Updated on 2026-03-18

15

Participants Needed

2

Research Sites

110 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The recommended volume resuscitation for patients with early sepsis-induced hypoperfusion is at least 30 ml/kg of crystalloid administered within the first three hours. However, this standardized approach does not account for individual patient variability and lacks personalization. Additionally, the effects of administering 30 ml/kg on intercompartmental fluid shifts between the plasma and interstitial compartments remain unclear. This study aims to describe the volume kinetics of administering 30 ml/kg of Ringer's Lactate in patients with early sepsis-induced hypoperfusion within the first three hours.

CONDITIONS

Official Title

Volume Kinetics of Fluid Resuscitation in Early Sepsis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of sepsis by Sepsis-3 criteria with sepsis-induced hypoperfusion before volume resuscitation
  • Hypotension requiring norepinephrine to keep mean arterial pressure at or above 65 mm Hg or as decided by the clinician
  • Or serum lactate level greater than 2 mmol/L (18 mg/dL)
  • Or acute oliguria with urine output less than 0.5 mL/kg/hour
  • Or mottled skin
  • Or capillary refill time longer than 3 seconds
Not Eligible

You will not qualify if you...

  • Received at least 1 liter of intravenous fluid in the 6 hours before screening, including crystalloids, colloids, or blood products
  • Known pregnancy
  • Other causes of lactic acidosis such as recent seizures, certain medications (linezolid, metformin, anti-retrovirals), poisoning, ischemic bowel, or mitochondrial disorders
  • End-stage kidney disease requiring chronic dialysis
  • Concurrent hemorrhagic or obstructive shock
  • Increased risk of fluid intolerance demonstrated by moderate or severe left or right ventricular systolic dysfunction on echocardiography
  • Hypoxemia index less than 200 mmHg or sonographic evidence of bilateral B or C lung profiles
  • Abdominal compartment syndrome
  • Post-cardiac arrest status

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Fundeni Clinical Institute

Bucharest, Bucharest, Romania, 022328

Actively Recruiting

2

"Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases

Bucharest, Romania, 022328

Actively Recruiting

Loading map...

Research Team

C

Cosmin Balan, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here